Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

miRNAs as Potential Treatment Targets and Treatment Options in Cancer
Nina Petrović, Sercan Ergün
Molecular Diagnosis & Therapy (2018) Vol. 22, Iss. 2, pp. 157-168
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

An overview of microRNAs: Biology, functions, therapeutics, and analysis methods
Kioomars Saliminejad, Hamid Reza Khorram Khorshid, Shahrzad Soleymani Fard, et al.
Journal of Cellular Physiology (2018) Vol. 234, Iss. 5, pp. 5451-5465
Closed Access | Times Cited: 1558
Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer—How We Can Rise to the Challenge
Milica Nedeljković, Ana Damjanović
Cells (2019) Vol. 8, Iss. 9, pp. 957-957
Open Access | Times Cited: 673
Epigenetic regulation in cardiovascular disease: mechanisms and advances in clinical trials
Yuncong Shi, Huanji Zhang, Suli Huang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 201
miRNAs as biomarkers for early cancer detection and their application in the development of new diagnostic tools
Leonardo J. Galvão-Lima, Antônio Higor Freire de Morais, Ricardo Alexsandro de Medeiros Valentim, et al.
BioMedical Engineering OnLine (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 114
Molecular Mechanisms, Biomarkers and Emerging Therapies for Chemotherapy Resistant TNBC
Paola Ferrari, Cristian Scatena, Matteo Ghilli, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1665-1665
Open Access | Times Cited: 104
The Role of miRNA in Tumor Immune Escape and miRNA-Based Therapeutic Strategies
Zhengjia Zhang, Qingcai Huang, Liuchunyang Yu, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 46
Therapeutic Potential of Natural Compounds Acting through Epigenetic Mechanisms in Cardiovascular Diseases: Current Findings and Future Directions
Paola Bontempo, Lucia Capasso, Luigi De Masi, et al.
Nutrients (2024) Vol. 16, Iss. 15, pp. 2399-2399
Open Access | Times Cited: 11
Emergence of MicroRNAs as Key Players in Cancer Cell Metabolism
Sugarniya Subramaniam, Varinder Jeet, Judith A. Clements, et al.
Clinical Chemistry (2019) Vol. 65, Iss. 9, pp. 1090-1101
Open Access | Times Cited: 70
Nanoparticle Delivery of miR-708 Mimetic Impairs Breast Cancer Metastasis
Divya Ramchandani, Seung Koo Lee, Shira Yomtoubian, et al.
Molecular Cancer Therapeutics (2019) Vol. 18, Iss. 3, pp. 579-591
Open Access | Times Cited: 67
Current paradigms in epigenetic anticancer therapeutics and future challenges
Manoj Singh, Vikas Kumar, Nirmala Sehrawat, et al.
Seminars in Cancer Biology (2021) Vol. 83, pp. 422-440
Closed Access | Times Cited: 49
Advances in the discovery of microRNA-based anticancer therapeutics: latest tools and developments
Kenneth K.W. To, Winnie Fong, Christy W.S. Tong, et al.
Expert Opinion on Drug Discovery (2019) Vol. 15, Iss. 1, pp. 63-83
Closed Access | Times Cited: 50
The Clinical Potential of Oligonucleotide Therapeutics against Pancreatic Cancer
Kazuki Takakura, Atsushi Kawamura, Yuichi Torisu, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 13, pp. 3331-3331
Open Access | Times Cited: 47
RETRACTED: miR-744-5p Inhibits Non-Small Cell Lung Cancer Proliferation and Invasion by Directly Targeting PAX2
Shaolin Chen, Fei Shi, Weixing Zhang, et al.
Technology in Cancer Research & Treatment (2019) Vol. 18
Open Access | Times Cited: 45
The Epigenetic Modulation of Cancer and Immune Pathways in Hepatitis B Virus-Associated Hepatocellular Carcinoma: The Influence of HBx and miRNA Dysregulation
Kurt Sartorius, Ping An, Cheryl A. Winkler, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 39
A comprehensive review of cancer therapies mediated by conjugated gold nanoparticles with nucleic acid
Sayedeh Azimeh Hosseini, Arefeh Kardani, Hajar Yaghoobi
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 127184-127184
Closed Access | Times Cited: 14
Regulation of cancer immune escape: The roles of miRNAs in immune checkpoint proteins
Qin Yang, Wenjie Cao, Zi Wang, et al.
Cancer Letters (2018) Vol. 431, pp. 73-84
Closed Access | Times Cited: 40
The Multiple Roles of Hepatitis B Virus X Protein (HBx) Dysregulated MicroRNA in Hepatitis B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) and Immune Pathways
Kurt Sartorius, Leo Swadling, Ping An, et al.
Viruses (2020) Vol. 12, Iss. 7, pp. 746-746
Open Access | Times Cited: 36
Emerging oncogene ATAD2: Signaling cascades and therapeutic initiatives
Aditi Nayak, Madhuri Dutta, Anasuya Roychowdhury
Life Sciences (2021) Vol. 276, pp. 119322-119322
Closed Access | Times Cited: 29
MicroRNA-217 modulates pancreatic cancer progression via targeting ATAD2
Madhuri Dutta, Biswajit Das, Debasish Mohapatra, et al.
Life Sciences (2022) Vol. 301, pp. 120592-120592
Closed Access | Times Cited: 19
MicroRNA-421-targeted PDCD4 regulates breast cancer cell proliferation
Yiwei Wang, Zipeng Liu, Jian Shen
International Journal of Molecular Medicine (2018)
Open Access | Times Cited: 37
<p>MicroRNA-497-5p Induces Cell Cycle Arrest Of Cervical Cancer Cells In S Phase By Targeting CBX4</p>
Yani Chen, Juan Du, Yu Wang, et al.
OncoTargets and Therapy (2019) Vol. Volume 12, pp. 10535-10545
Open Access | Times Cited: 32
The Roles of Noncoding RNAs in Systemic Sclerosis
Yongmei Liu, Linlin Cheng, Haoting Zhan, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
The miRNA Expression Profile of Experimental Autoimmune Encephalomyelitis Reveals Novel Potential Disease Biomarkers
Shivaprasad H. Venkatesha, Steven Dudics, Yang Song, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 12, pp. 3990-3990
Open Access | Times Cited: 31
Discovery of the Biginelli hybrids as novel caspase-9 activators in apoptotic machines: Lipophilicity, molecular docking study, influence on angiogenesis gene and miR-21 expression levels
Nenad Janković, Jovana Trifunović Ristovski, Milan Vraneš, et al.
Bioorganic Chemistry (2019) Vol. 86, pp. 569-582
Closed Access | Times Cited: 27
miRNA as promising theragnostic biomarkers for predicting radioresistance in cancer: A systematic review and meta‐analysis
Chiman Mohammadi, Saeideh Gholamzadeh Khoei, Nashmin Fayazi Hosseini, et al.
Critical Reviews in Oncology/Hematology (2020) Vol. 157, pp. 103183-103183
Closed Access | Times Cited: 24
Page 1 - Next Page

Scroll to top